We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
+12.2%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$483M
AUM Growth
+$37.3M
(+8.4%)
Cap. Flow
-$6.9M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
54
New
2
Increased
–
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beam Therapeutics
BEAM
|
+$2.36M |
| 2 |
Pacific Biosciences
PACB
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$3.23M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$2.6M |
| 3 |
Becton Dickinson
BDX
|
+$2.46M |
| 4 |
Apple
AAPL
|
+$1.36M |
| 5 |
RTX Corp
RTX
|
+$727K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.02% |
| 2 | Healthcare | 20.2% |
| 3 | Industrials | 16.73% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Communication Services | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$32.6B
| $8.3M | 1.72% |
22,436
| – | – |
|
27
T-Mobile US
TMUS
$195B
| $8.24M | 1.71% |
71,030
| – | – |
|
28
Sysco
SYY
$39.3B
| $7.7M | 1.59% |
98,015
| – | – |
|
29
Lowe's Companies
LOW
$117B
| $7.26M | 1.5% |
28,100
| – | – |
|
30
Home Depot
HD
$329B
| $7.05M | 1.46% |
17,000
| – | – |
|
31
Alphabet (Google) Class C
GOOG
$4.19T
| $6.53M | 1.35% |
45,120
| – | – |
|
32
Zoetis
ZTS
$32B
| $6.06M | 1.25% |
24,818
| – | – |
|
33
Stryker
SYK
$127B
| $5.12M | 1.06% |
19,145
| – | – |
|
34
Adobe
ADBE
$116B
| $5.1M | 1.06% |
9,000
| – | – |
|
35
Walmart Inc
WMT
$820B
| $4.78M | 0.99% |
99,000
| – | – |
|
36
Colgate-Palmolive
CL
$72.3B
| $4.37M | 0.9% |
51,200
| – | – |
|
37
Medtronic
MDT
$117B
| $3.88M | 0.8% |
37,550
| – | – |
|
38
CSX Corp
CSX
$95B
| $3.83M | 0.79% |
102,000
| – | – |
|
|
39
RTX Corp
RTX
$285B
| $3.3M | 0.68% |
38,348
-8,348
| -18% | -$727K |
|
40
3M
MMM
$89.9B
| $2.84M | 0.59% |
19,136
| – | – |
|
|
41
Beam Therapeutics
BEAM
$3.03B
| $2.19M | 0.45% |
+27,550
| New | +$2.36M |
|
|
WIRE
42
DELISTED
Encore Wire Corp
WIRE
| $1.86M | 0.39% |
13,000
| – | – |
|
|
43
Pacific Biosciences
PACB
$435M
| $1.7M | 0.35% |
+82,875
| New | +$2M |
|
44
Merck
MRK
$366B
| $1.66M | 0.34% |
21,700
| – | – |
|
45
Pfizer
PFE
$159B
| $1.45M | 0.3% |
24,500
| – | – |
|
46
Cigna
CI
$73.7B
| $1.34M | 0.28% |
5,841
| – | – |
|
47
Canadian National Railway
CNI
$76.2B
| $1.24M | 0.26% |
10,050
| – | – |
|
48
Fortive
FTV
$18B
| $1.14M | 0.24% |
19,905
| – | – |
|
49
ExxonMobil
XOM
$644B
| $1M | 0.21% |
16,400
| – | – |
|
50
J.M. Smucker
SJM
$14.1B
| $231K | 0.05% |
1,700
| – | – |
|
Similar funds
PLU
RR
TAIM
KGAMU
GPWA
MAC
BT
IC
Chad R. Baker's Q4 2021 Portfolio in Review
As of Q4 2021, Chad R. Baker held 54 positions worth $483M, up 8.4% from $446M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Chad R. Baker's Q4 2021 filing shows 2 new, 4 reduced and 4 closed positions. Its largest new stake was Beam Therapeutics: 27,550 shares worth $2.19M. The largest sale was Teladoc Health, an estimated $3.23M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Chad R. Baker's largest Q4 2021 buy was Beam Therapeutics: 27,550 shares worth $2.19M.
- Chad R. Baker's biggest Q4 2021 reduction was Apple, cutting an estimated $1.36M.
- Chad R. Baker fully exited Teladoc Health in Q4 2021, selling an estimated $3.23M.
- Chad R. Baker's ten largest holdings make up 44% of its $483M portfolio in Q4 2021.
- Chad R. Baker opened 2 new positions and closed 4 in Q4 2021.
- Chad R. Baker's portfolio value rose 8.4% quarter-over-quarter to $483M.
Based on Chad R. Baker's 13F filing for Q4 2021, filed 8 Feb 2022.